Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pena

Showing results (171-180 of 275) with videos related to

Pageof 28
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|July 31, 2009
Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokineticsJ Algorta, M A Pena, A Alvarez, et al.
The European Respiratory Journal|January 6, 2011
Interferon-γ release assays in tuberculosis contacts: is there a window period?L Anibarro, M Trigo, C Villaverde, et al.
Neurology|October 7, 2009
Teaching video neuroimages: excessive grinning in Wilson diseaseR S Cetlin, G R Rodrigues, M A Pena-Pereira, et al.
Microbiology (Reading, England)|March 24, 2007
Helicobacter hepaticus catalase shares surface-predicted epitopes with mammalian catalasesEssam J Alyamani, Petra Brandt, Jeremy A Pena, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 29, 1997
Interaction of family history of atherosclerosis with atherogenic lipid traits in men with non-coronary atherosclerosisM Sentí, J Pedro-Botet, M Pavesi, et al.
Molecular Endocrinology (Baltimore, Md.)|July 31, 2004
Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptorS Derick, A Pena, T Durroux, et al.
Revista Clinica Espanola|June 1, 1987
[Fever of unknown origin. A retrospective study of 45 cases]P Diz Dios, C Martínez Vázquez, P Mardomingo, et al.
Journal of Cellular Physiology|April 1, 1993
Epidermal growth factor receptors lose ligand binding ability as WI-38 cells progress from short-term to long-term quiescenceA M Donigan, R C Cavalli, A A Pena, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|April 18, 2015
[Complicated pleural infection: Analysis of 2 consecutive cohorts managed with a different policy]L Moral, C Loeda, F Gómez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 19, 2008
Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral dosesJ Algorta, M A Pena, C Maraschiello, et al.
Pageof 28

Showing results (171-180 of 275) with videos related to

Sort By:
Pageof 28
International Journal of Clinical Pharmacology and Therapeutics|July 31, 2009
Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokineticsJ Algorta, M A Pena, A Alvarez, et al.
The European Respiratory Journal|January 6, 2011
Interferon-γ release assays in tuberculosis contacts: is there a window period?L Anibarro, M Trigo, C Villaverde, et al.
Neurology|October 7, 2009
Teaching video neuroimages: excessive grinning in Wilson diseaseR S Cetlin, G R Rodrigues, M A Pena-Pereira, et al.
Microbiology (Reading, England)|March 24, 2007
Helicobacter hepaticus catalase shares surface-predicted epitopes with mammalian catalasesEssam J Alyamani, Petra Brandt, Jeremy A Pena, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 29, 1997
Interaction of family history of atherosclerosis with atherogenic lipid traits in men with non-coronary atherosclerosisM Sentí, J Pedro-Botet, M Pavesi, et al.
Molecular Endocrinology (Baltimore, Md.)|July 31, 2004
Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptorS Derick, A Pena, T Durroux, et al.
Revista Clinica Espanola|June 1, 1987
[Fever of unknown origin. A retrospective study of 45 cases]P Diz Dios, C Martínez Vázquez, P Mardomingo, et al.
Journal of Cellular Physiology|April 1, 1993
Epidermal growth factor receptors lose ligand binding ability as WI-38 cells progress from short-term to long-term quiescenceA M Donigan, R C Cavalli, A A Pena, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|April 18, 2015
[Complicated pleural infection: Analysis of 2 consecutive cohorts managed with a different policy]L Moral, C Loeda, F Gómez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 19, 2008
Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral dosesJ Algorta, M A Pena, C Maraschiello, et al.
Pageof 28